Publication | Closed Access
Development of [177Lu]Lu-LNC1003 for radioligand therapy of prostate cancer with a moderate level of PSMA expression
41
Citations
34
References
2023
Year
UrologyModerate LevelRadiation TherapyMedicinePsma ExpressionRadiopharmaceutical TherapyCancer TreatmentProstatic DiseaseOncologyCell BiologyNuclear MedicineCancer Research
| Year | Citations | |
|---|---|---|
Page 1
Page 1